|
ATL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.987600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.159000E-01 |
| Normal-vs-Stage2 |
6.239800E-01 |
| Normal-vs-Stage3 |
5.666600E-01 |
| Normal-vs-Stage4 |
6.619400E-01 |
| Stage1-vs-Stage2 |
2.621200E-01 |
| Stage1-vs-Stage3 |
2.959200E-01 |
| Stage1-vs-Stage4 |
4.965400E-01 |
| Stage2-vs-Stage3 |
9.295400E-01 |
| Stage2-vs-Stage4 |
9.337400E-01 |
| Stage3-vs-Stage4 |
9.880800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.000000E-01 |
| Normal-vs-AfricanAmerican |
5.706000E-01 |
| Normal-vs-Asian |
4.141400E-01 |
| Caucasian-vs-AfricanAmerican |
6.532200E-01 |
| Caucasian-vs-Asian |
4.213400E-01 |
| AfricanAmerican-vs-Asian |
4.174400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.533200E-01 |
| Normal-vs-Female |
6.394400E-02 |
| Male-vs-Female |
1.433880E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.563200E-01 |
| Normal-vs-Extreme_Weight |
5.100200E-01 |
| Normal-vs-Obese |
3.533800E-01 |
| Normal-vs-Extreme_Obese |
2.048000E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.136240E-01 |
| Normal_Weight-vs-Obese |
9.140400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.162600E-03 |
| Extreme_Weight-vs-Obese |
4.932300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.544300E-02 |
| Obese-vs-Extreme_Obese |
1.150490E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.960600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.539190E-01 |
| Normal-vs-Age(61-80Yrs) |
5.304600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.170800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.171800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.952200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.701600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.024800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.863950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.321000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.942200E-01 |
| Normal-VS-Type2 PRCC |
3.320200E-01 |
| Normal-VS-KIRP CIMP |
1.304750E-01 |
| Normal-VS-Unclassified PRCC |
3.293600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.001600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.285200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.518000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.407800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.175600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.467000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.680400E-01 |
| Normal-vs-N1 |
8.970400E-01 |
| Normal-vs-N2 |
6.621800E-01 |
| N0-vs-N1 |
4.445800E-01 |
| N0-vs-N2 |
8.288800E-01 |
| N1-vs-N2 |
5.653400E-01 |
|
|
